PRIMIWAL S TABLET

PRIMIWAL S TABLET is a pharmaceutical preparation that contains Sildenafil, a potent inhibitor of phosphodiesterase type 5 (PDE5), as its active ingredient. The tablet is formulated to provide a precise dose of 25mg of Sildenafil, which is a commonly prescribed medication for the treatment of erectile dysfunction (ED) in adult males. The chemical name of Sildenafil is 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate, and its molecular formula is C22H30N6O4S. The medication is designed to be taken orally, and its onset of action is typically within 30 minutes to 1 hour after administration. The pharmacokinetic profile of PRIMIWAL S TABLET reveals that Sildenafil is rapidly absorbed into the bloodstream, with peak plasma concentrations achieved within 30 minutes to 2 hours after oral administration. The bioavailability of Sildenafil is approximately 40%, and it is extensively bound to plasma proteins, primarily albumin. The medication is metabolized primarily in the liver by the cytochrome P450 enzyme system, with the major metabolite being N-desmethylsildenafil, which has a similar pharmacological profile to the parent compound. The elimination half-life of Sildenafil is approximately 3-4 hours, and it is excreted primarily in the feces and to a lesser extent in the urine. The tablet formulation of PRIMIWAL S TABLET is designed to provide a controlled release of Sildenafil, ensuring a prolonged duration of action and minimizing the risk of adverse effects.

PRIMIWAL S TABLET is primarily indicated for the treatment of erectile dysfunction (ED) in adult males, which is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. The medication works by enhancing the effects of nitric oxide, a natural chemical in the body that relaxes and dilates blood vessels, thereby increasing blood flow to the penis and facilitating an erection. PRIMIWAL S TABLET is also used to treat pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries that supply blood to the lungs. In this context, Sildenafil helps to reduce the blood pressure in the lungs, improving exercise tolerance and delaying the progression of the disease. In addition to its primary indications, PRIMIWAL S TABLET has been investigated for its potential therapeutic benefits in other conditions, such as Raynaud's phenomenon, a disorder characterized by vasospasm of the blood vessels in response to cold temperatures or stress. Sildenafil has been shown to improve blood flow to the affected areas, reducing the frequency and severity of vasospastic episodes. Furthermore, the medication has been studied for its potential use in the treatment of female sexual arousal disorder (FSAD), a condition characterized by a lack of sexual desire or arousal in women. While the results of these studies are promising, further research is needed to fully establish the efficacy and safety of PRIMIWAL S TABLET in these contexts.

The primary benefit of PRIMIWAL S TABLET is its ability to effectively treat erectile dysfunction (ED) in adult males, restoring their ability to achieve and maintain an erection sufficient for satisfactory sexual performance. This can have a significant impact on the quality of life of affected individuals, improving their self-esteem, confidence, and overall well-being. Additionally, the medication has been shown to improve the quality of life of patients with pulmonary arterial hypertension (PAH), enhancing their exercise tolerance and delaying the progression of the disease. The use of PRIMIWAL S TABLET has also been associated with improved relationships and social interactions, as individuals are able to engage in sexual activity with greater confidence and frequency. The benefits of PRIMIWAL S TABLET extend beyond its therapeutic effects, as it has been shown to be a cost-effective treatment option for ED and PAH. The medication is generally well-tolerated, with a low incidence of adverse effects, and it can be taken orally, eliminating the need for invasive or cumbersome treatments. Furthermore, the use of PRIMIWAL S TABLET has been associated with improved patient compliance, as individuals are more likely to adhere to a treatment regimen that is easy to use and effective. The medication has also been shown to have a positive impact on the mental health and well-being of affected individuals, reducing anxiety and depression and improving overall quality of life.

PRIMIWAL S TABLET is generally well-tolerated, with most adverse effects being mild and transient. The most common side effects reported with the use of Sildenafil include headache, facial flushing, indigestion, and nasal congestion. These effects are usually dose-related and can be minimized by adjusting the dosage or taking the medication with food. Less common side effects include dizziness, blurred vision, and priapism, a condition characterized by a prolonged and painful erection. In rare cases, Sildenafil can cause more serious adverse effects, such as myocardial infarction, stroke, and severe hypotension. The risk of adverse effects with PRIMIWAL S TABLET can be increased in certain individuals, such as those with pre-existing medical conditions or those taking concomitant medications. For example, individuals with a history of cardiovascular disease, such as heart failure or coronary artery disease, may be at increased risk of cardiovascular adverse effects. Similarly, individuals taking nitrates or other medications that lower blood pressure may be at increased risk of hypotension. It is essential to carefully evaluate the benefits and risks of PRIMIWAL S TABLET in each individual patient, taking into account their medical history, current medications, and other factors that may influence the risk of adverse effects.

PRIMIWAL S TABLET should be taken orally, approximately 30 minutes to 1 hour before sexual activity. The recommended dose is 25mg, which can be adjusted based on individual response and tolerability. The medication should be taken with a full glass of water, and it can be taken with or without food. However, taking the medication with a high-fat meal may delay its onset of action. It is essential to follow the recommended dosage and administration instructions carefully, as excessive doses or improper use can increase the risk of adverse effects. The use of PRIMIWAL S TABLET requires careful consideration of the individual patient's medical history and current medications. For example, individuals with a history of cardiovascular disease or those taking certain medications, such as nitrates or alpha-blockers, may require dose adjustments or special monitoring. Additionally, individuals with renal or hepatic impairment may require dose adjustments, as the medication is metabolized and eliminated by these organs. It is essential to consult with a healthcare provider before taking PRIMIWAL S TABLET, especially if you have any pre-existing medical conditions or are taking concomitant medications.

PRIMIWAL S TABLET works by enhancing the effects of nitric oxide, a natural chemical in the body that relaxes and dilates blood vessels. During sexual stimulation, nitric oxide is released from the nerve endings in the penis, causing the blood vessels to relax and dilate. This increases blood flow to the penis, facilitating an erection. Sildenafil, the active ingredient in PRIMIWAL S TABLET, inhibits the action of phosphodiesterase type 5 (PDE5), an enzyme that breaks down nitric oxide. By inhibiting PDE5, Sildenafil increases the levels of nitric oxide in the penis, enhancing its relaxing and dilating effects on the blood vessels. The mechanism of action of PRIMIWAL S TABLET is highly specific, targeting the PDE5 enzyme in the penis and minimizing the risk of adverse effects in other parts of the body. The medication has a high affinity for PDE5, with a potency that is approximately 10-20 times greater than its affinity for other PDE isoforms. This selectivity is essential for minimizing the risk of adverse effects, such as those affecting the cardiovascular system or the visual system. The use of PRIMIWAL S TABLET has been shown to be effective in a wide range of patients, including those with ED of various etiologies, such as vasculogenic, neurogenic, or psychogenic ED.

PRIMIWAL S TABLET should be used with caution in certain individuals, such as those with a history of cardiovascular disease, including heart failure, coronary artery disease, or cardiac arrhythmias. The medication can cause a decrease in blood pressure, which can be problematic in individuals with pre-existing hypotension or those taking medications that lower blood pressure. Additionally, PRIMIWAL S TABLET should be used with caution in individuals with a history of priapism, a condition characterized by a prolonged and painful erection. The medication should also be used with caution in individuals with a history of bleeding disorders or those taking anticoagulant medications, as it can increase the risk of bleeding. The use of PRIMIWAL S TABLET requires careful consideration of the individual patient's medical history and current medications. For example, individuals with a history of liver or kidney disease may require dose adjustments, as the medication is metabolized and eliminated by these organs. Additionally, individuals taking certain medications, such as erythromycin or ketoconazole, may require dose adjustments, as these medications can increase the levels of Sildenafil in the body. It is essential to consult with a healthcare provider before taking PRIMIWAL S TABLET, especially if you have any pre-existing medical conditions or are taking concomitant medications.

PRIMIWAL S TABLET should not be used in certain individuals, such as those with a known hypersensitivity to Sildenafil or any other ingredient in the medication. The medication should also not be used in individuals with a history of non-arteritic anterior ischemic optic neuropathy (NAION), a condition characterized by sudden and severe vision loss. Additionally, PRIMIWAL S TABLET should not be used in individuals with a history of retinitis pigmentosa, a genetic disorder that affects the retina. The medication should also not be used in individuals taking nitrates or other medications that lower blood pressure, as it can cause a significant decrease in blood pressure. The use of PRIMIWAL S TABLET requires careful consideration of the individual patient's medical history and current medications. For example, individuals with a history of pulmonary veno-occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH) should not use the medication, as it can worsen these conditions. Additionally, individuals with a history of heart failure or coronary artery disease should use the medication with caution, as it can increase the risk of cardiovascular adverse effects. It is essential to consult with a healthcare provider before taking PRIMIWAL S TABLET, especially if you have any pre-existing medical conditions or are taking concomitant medications.